ESR1 and cancer: Furthermore, DNA hypermethylation and concomitant loss of ER binding at enhancers was found to be a key event associated with alterations in 3D chromatin interactions; highly dynamic ER-bound enhancer-promoter interactions have been shown to mediate expression of cancer invasion and aggressiveness genes in endocrine-resistance [39,40].